H16203D human AB serum 100ML BOT TLE
Ended Awarded Last action
- Contract number
- HHSN261NCH56248
- Awardee
-
Gemini Bioproducts LLC UEI TPLGWKT6AM88
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $22,675
Award facts
- Contract value
-
- $22,675.00 Current, with exercised options
- $0.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Not on record Potential, with all options
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- NAICS code
- 621511 Medical Laboratories
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- 0 offers Simplified Acquisition
- Pricing
- Other
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN261NCH56248?
HHSN261NCH56248 was awarded to Gemini Bioproducts LLC by National Cancer Institute (National Institutes of Health) on May 16, 2006.
How much is contract HHSN261NCH56248 worth?
The government has obligated $22,675 on HHSN261NCH56248.
Which agency awarded contract HHSN261NCH56248?
National Cancer Institute (National Institutes of Health) awarded HHSN261NCH56248, with funding from Office of the Director (National Institutes of Health).
Is contract HHSN261NCH56248 an order under another contract?
Yes. HHSN261NCH56248 is a BPA call under HHSN263199700048255B, a blanket purchase agreement.
Was contract HHSN261NCH56248 competed?
The government received 0 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award